Clinical trial
Exploiting the Gut Microbiota and Its Metabolites in Pelvic Cancer
NCT05605353 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploiting the Gut Microbiota and Its Metabolites in Pelvic Cancer
- Lead sponsor
- University of Aberdeen
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 1, 2023
- Completion date
- May 31, 2029
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pelvic neoplasm